Zacks: Analysts Expect Maximus, Inc. (NYSE:MMS) Will Post Earnings of $0.82 Per Share


Share on StockTwits

Wall Street brokerages forecast that Maximus, Inc. (NYSE:MMS) will announce $0.82 earnings per share for the current fiscal quarter, according to Zacks Investment Research. Three analysts have provided estimates for Maximus’ earnings, with the highest EPS estimate coming in at $0.86 and the lowest estimate coming in at $0.77. Maximus reported earnings of $0.43 per share during the same quarter last year, which suggests a positive year over year growth rate of 90.7%. The firm is expected to report its next quarterly earnings results on Thursday, May 6th.

According to Zacks, analysts expect that Maximus will report full-year earnings of $3.68 per share for the current fiscal year, with EPS estimates ranging from $3.66 to $3.70. For the next financial year, analysts forecast that the business will post earnings of $4.30 per share, with EPS estimates ranging from $4.13 to $4.42. Zacks Investment Research’s EPS calculations are a mean average based on a survey of research firms that follow Maximus.

Maximus (NYSE:MMS) last posted its quarterly earnings data on Thursday, February 4th. The health services provider reported $1.03 earnings per share for the quarter, beating the consensus estimate of $0.94 by $0.09. Maximus had a return on equity of 17.60% and a net margin of 6.20%. The company had revenue of $945.60 million during the quarter, compared to analysts’ expectations of $846.46 million. During the same period in the prior year, the business earned $0.91 earnings per share. Maximus’s revenue for the quarter was up 15.6% compared to the same quarter last year.

Several research firms have recently weighed in on MMS. Raymond James increased their price objective on Maximus from $90.00 to $96.00 and gave the company a “strong-buy” rating in a research report on Friday, February 5th. TheStreet raised Maximus from a “c+” rating to a “b-” rating in a research report on Tuesday, November 10th.

In related news, Vice Chairman Richard A. Montoni sold 12,000 shares of the company’s stock in a transaction on Tuesday, December 8th. The stock was sold at an average price of $70.72, for a total value of $848,640.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Vice Chairman Richard A. Montoni sold 11,000 shares of the company’s stock in a transaction on Thursday, December 10th. The shares were sold at an average price of $71.27, for a total value of $783,970.00. The disclosure for this sale can be found here. Insiders sold 28,529 shares of company stock valued at $2,033,131 over the last 90 days. 2.00% of the stock is currently owned by corporate insiders.

A number of institutional investors have recently added to or reduced their stakes in MMS. Fieldpoint Private Securities LLC acquired a new position in Maximus during the fourth quarter worth $32,000. Point72 Hong Kong Ltd raised its stake in Maximus by 1,675.8% during the third quarter. Point72 Hong Kong Ltd now owns 586 shares of the health services provider’s stock worth $40,000 after acquiring an additional 553 shares in the last quarter. CI Investments Inc. acquired a new position in Maximus during the third quarter worth $43,000. JJJ Advisors Inc. raised its stake in Maximus by 372.9% during the fourth quarter. JJJ Advisors Inc. now owns 681 shares of the health services provider’s stock worth $50,000 after acquiring an additional 537 shares in the last quarter. Finally, Planned Solutions Inc. acquired a new position in Maximus during the fourth quarter worth $51,000. Hedge funds and other institutional investors own 92.89% of the company’s stock.

Shares of MMS traded up $0.18 during mid-day trading on Tuesday, hitting $83.31. The company’s stock had a trading volume of 7,413 shares, compared to its average volume of 383,444. Maximus has a one year low of $46.42 and a one year high of $84.73. The company has a debt-to-equity ratio of 0.01, a quick ratio of 1.66 and a current ratio of 1.66. The firm has a market capitalization of $5.12 billion, a PE ratio of 24.45 and a beta of 0.84. The stock’s 50-day moving average is $78.59 and its two-hundred day moving average is $73.83.

The company also recently announced a quarterly dividend, which will be paid on Friday, February 26th. Investors of record on Friday, February 12th will be paid a $0.28 dividend. The ex-dividend date is Thursday, February 11th. This represents a $1.12 dividend on an annualized basis and a dividend yield of 1.34%. Maximus’s payout ratio is 33.04%.

About Maximus

Maximus, Inc provides business process services (BPS) to government health and human services programs worldwide. It operates through three segments: U.S. Services, U.S. Federal Services, and Outside the U.S. The U.S. Services segment offers various BPS solutions, such as program administration, appeals and assessments, and related consulting works for U.S.

Read More: Technical Indicators – What is a Golden Cross?

Get a free copy of the Zacks research report on Maximus (MMS)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.